This is a very rare condition that makes children age much faster than they should. It causes many signs of aging, like gray hair, hair loss, hearing loss, and problems with bones and joints, starting in early childhood.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Progeria, formally Hutchinson-Gilford progeria syndrome (HGPS), is an extremely rare genetic condition in which features that resemble rapid aging appear in early childhood. Babies with progeria usually look healthy at birth. Within the first year or two, growth slows sharply, and children lose their hair and the layer of fat under the skin. The skin looks thin and aged, joints become stiff, and the hips are prone to dislocating. Children share a recognizable appearance, with a small face and jaw, prominent eyes and a thin nose. The most serious effect is on blood vessels. Starting in childhood, the arteries thicken, stiffen and narrow, much as they do in older adults with heart disease. This is what leads to heart attacks, strokes and heart failure at a young age, and it is the main factor that shapes how long people with progeria live. Progeria does not affect intelligence or the development of skills such as sitting, standing and walking. It also does not reproduce every part of aging: cataracts and the wear-and-tear arthritis common in older adults are not typical features. Several other rare conditions are sometimes loosely called progeria or "progeroid" syndromes, but they have different genetic causes and courses, so the specific diagnosis matters.
Progeria is caused by a change in a gene called LMNA, which carries instructions for lamin A, a protein that acts as scaffolding for the envelope around each cell's nucleus. The change produces an abnormal version of the protein called progerin. Progerin makes the nucleus unstable and damages cells over time, and the harm seems greatest in tissues that handle constant physical force, such as blood vessels, bones and joints. In almost every case, the gene change happens by chance around the time of conception. Parents and brothers or sisters are virtually never affected, and nothing a parent did before or during pregnancy causes it. Progeria affects boys and girls and every ethnic background equally, and it occurs in roughly 1 in 4 million births. For parents who already have a child with progeria, the chance of it happening again is higher than in the general population, about 2 to 3 percent, because a parent can rarely carry the change in a small share of their own cells without having the condition. A genetic counselor can explain what this means for a particular family.
Progeria is usually suspected in the second year of life, when slowed growth, hair loss and skin changes become noticeable. Occasionally an early clue is tight, firm skin over the belly or thighs in infancy. A clinician who recognizes the pattern will examine the child, review growth over time and take a careful history. The diagnosis is confirmed with a genetic test that looks for a change in the LMNA gene. About 9 in 10 children with progeria have the same single change, known as classic HGPS. Testing also separates progeria from look-alike conditions, which matters because the approved treatment works only for progeria and a few closely related forms. In the United States, the Progeria Research Foundation offers this testing at no cost to families. After diagnosis, a baseline evaluation usually includes a heart assessment and imaging to see how the arteries, heart, brain, hips and other bones are affected. These measurements guide care and are repeated over time.
There is no cure for progeria, but treatment can lengthen life and ease many of its effects. The one approved medicine is lonafarnib (Zokinvy), a capsule taken twice daily with meals. It blocks a chemical step that lets progerin build up in the cell's nucleus. In the United States it is approved for children 12 months and older who have reached a minimum body size (measured as body surface area, calculated from height and weight), because a suitable dose is not available for smaller children. Lonafarnib's main benefit is on the arteries, the heart and bones, and on survival. In studies comparing treated children with similar untreated children, those taking it lived about two and a half years longer on average over up to 11 years of follow-up. The evidence comes from small open trials compared with historical records rather than randomized trials, which is common for a disease this rare. It does not improve hair, skin or joint stiffness. Nausea, vomiting, diarrhea and reduced appetite are common at first and often ease within weeks to months. Treatment involves regular heart rhythm tests (ECGs), blood tests, kidney checks and eye exams. Lonafarnib interacts with many other medicines, including the cholesterol drugs lovastatin, simvastatin and atorvastatin and the sedative midazolam, so every prescriber, pharmacist and surgical team needs to know about it. It can harm a developing pregnancy, which becomes relevant for young adults. Day-to-day care is also important. Low-dose aspirin is often prescribed to help prevent heart attacks and strokes, and staying well hydrated helps keep blood flowing to the brain and heart. Physical and occupational therapy help preserve joint movement and independence, and adaptive equipment and home changes make daily tasks easier. Children grow slowly no matter how much they eat, so the goal is nutritious, calorie-rich food by mouth rather than tube feeding to force growth. Care is best coordinated by a team that includes a pediatrician, a cardiologist, an orthopedic specialist, therapists, and hearing and dental care. Any planned sedation or surgery should involve an anesthesia team prepared for a challenging airway. Researchers are studying additional drugs and gene-based approaches in clinical trials, but none is yet an established treatment.
Progeria is a progressive condition. Without lonafarnib, children with progeria have lived to about 14.5 years on average, with a range of roughly 8 to 21 years, most often dying of heart disease or stroke. Lonafarnib has added to that average, and individual courses vary, especially between classic progeria and less common forms. Children grow at a very slow but steady rate; a 10-year-old is often about the height of an average 3-year-old. Thinking, learning and social development are typical, and most children attend school and take part in everyday life with practical adjustments. These may include seat cushions and rest breaks, mobility aids for longer distances, sitting near the front of the classroom because mild low-frequency hearing loss is common, and avoiding trampolines, bouncy houses and other uneven surfaces that can dislocate a hip. Drinking plenty of fluids matters every day and especially during illness and travel, because dehydration raises the risk of stroke symptoms. Strokes and mini-strokes are a real concern as the arteries narrow. Although they are not usually the cause of death, they can leave lasting effects on movement, speech or vision. Regular follow-up with heart tests, brain imaging, hearing checks, dental care and bone assessments helps the care team catch changes early and adjust treatment. Many families find support and expert guidance through the Progeria Research Foundation, which also connects families with clinical trials.
See a pediatrician if a baby or toddler's growth slows markedly alongside hair loss, loss of body fat or unusual tightening of the skin, and ask whether a genetic evaluation makes sense. For a child already diagnosed, contact the care team promptly about new or worsening headaches, hip pain or a new limp, vomiting or diarrhea that makes it hard to keep fluids down, or any new change in vision while taking lonafarnib. Call 911 right away for signs of a stroke or mini-stroke: sudden weakness or numbness in the face, an arm or a leg, especially on one side; trouble speaking; loss of vision; confusion; or a sudden severe headache with no known cause. Do this even if the symptoms go away. Also call 911 for chest pain or pressure, pain spreading to the arm or jaw, or sudden shortness of breath or lightheadedness, since these can signal a heart attack. Tell the emergency team that the child has progeria, because blood draws, IV lines and airway care need extra skill, and some standard heart medicines can lower blood pressure in ways that raise stroke risk.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Progeria is like, what's helped you, or ask the community a question.